U

UBCare Co Ltd
KOSDAQ:032620

Watchlist Manager
UBCare Co Ltd
KOSDAQ:032620
Watchlist
Price: 4 055 KRW 1.63% Market Closed
Market Cap: ₩211.7B

UBCare Co Ltd
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

UBCare Co Ltd
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
U
UBCare Co Ltd
KOSDAQ:032620
Other
₩6.7B
CAGR 3-Years
N/A
CAGR 5-Years
76%
CAGR 10-Years
N/A
I
Infinitt Healthcare Co Ltd
KOSDAQ:071200
Other
₩834.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-5%
L
LifeSemantics Corp
KOSDAQ:347700
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Other
-₩26.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Other
-₩278.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

UBCare Co Ltd
Glance View

Market Cap
211.7B KRW
Industry
Health Care

UBcare Co., Ltd. engages in the provision of healthcare solutions. The company is headquartered in Seoul, Seoul. The firm mainly operates in two segments. The Medical Information Platform segment provides integrated information solutions providing medical services. The Personal Health Information Management Platform segment provides health management services. In addition, the Company distributes medical instrument and green agricultural products, as well as operates electronic commerce business.

Intrinsic Value
4 762.71 KRW
Undervaluation 15%
Intrinsic Value
Price
U

See Also

What is UBCare Co Ltd's Other?
Other
6.7B KRW

Based on the financial report for Dec 31, 2025, UBCare Co Ltd's Other amounts to 6.7B KRW.

What is UBCare Co Ltd's Other growth rate?
Other CAGR 5Y
76%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett